Oral SYK/JAK Inhibitor Gusacitinib for the Treatment of Chronic Hand Eczema: Results of a Randomized Phase 2 Study

By sjmartinez • April 25, 2023

Jimenez PA, Sofen HL, Bissonnette R, Lee M, Fowler J, Zammit DJ, Chen Y, Rao N, Denis L, Gupta S. Oral SYK/JAK Inhibitor Gusacitinib for the Treatment of Chronic Hand Eczema: Results of a Randomized Phase 2 Study. J Am Acad Dermatol. 2023 Apr 22:S0190-9622(23)00724-7. doi: 10.1016/j.jaad.2023.04.027. Epub ahead of print. PMID: 37094653.

Tags: Chronic Hand Eczema, Dermatology, Janase Kinase Inhibitor, modified Total Lesion Symptom Score, Olive View DoM, Physician Global Assessment, Publications, Spleen Kinase Inhibitor

Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture method

Li YR, Zhou Y, Yu J, Kim YJ, Li M, Lee D, Zhou K, Chen Y, Zhu Y, Wang YC, Li Z, Yu Y, Dunn[...]

A novel microporous biomaterial vaccine platform for long-lasting antibody mediated immunity against viral infection

Mayer DP, Neslon ME, Andriyanova D, Filler RB, Ökten A, Antao OQ, Chen JS, Scumpia PO, Weaver WM, Wilen CB, Deshayes S, Weinstein JS. A[...]

Cutaneous Applications of the Antiviral Drug Cidofovir: A Review

Poppens M, Ruci A, Davis J. Cutaneous Applications of the Antiviral Drug Cidofovir: A Review. J Clin Med. 2024 Apr 23;13(9):2462. doi: 10.3390/jcm13092462. PMID: 38730991;[...]